MARC-PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of MARC-PHARMA is 2.9% (moderate). The 2025 annual accounts show equity of €21,193 and a net result of €16,193. Its solvency ranks better than 72% of 22,581 sector peers (NACE 47, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
1 director, no change since 2024
Board 1
FAIDHERBE Marc-Louis Hubert
CurrentAdministrateur non statutaire et de représentant permanent · since 30-12-2024
Other functions 1
FAIDHERBE Marc-Louis Hubert
CurrentAdministrateur non statutaire et de représentant permanent · since 30-12-2024
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
1 person since 2024, 1 in office
- Board
- Other function
| Name | Functions and periods |
|---|---|
| FAIDHERBE Marc-Louis Hubert |
|
Owners and capital
Capital and shareholders
Capital over the years
- 30-12-2024 Incorporation · €5,000 · 50 shares